Search for Tradename: PULMICORT RESPULES

Summary for Tradename: PULMICORT RESPULES

Patents:	3
Applicants:	1
NDAs:	1
2009 Sales:	$607,397,000
Therapeutic Class:	Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) Inflammatory Bowel Disease Agents Respiratory Tract Agents

Latest news for PULMICORT

AstraZeneca Doubles Share Buyback Target After Strong Q2, H1 Results; FDA Panel Backs Brilinta - Update

29 July 2010, 6:51 am

AstraZeneca shares up as drug maker lifts outlook

29 July 2010, 5:55 am

AstraZeneca Upgrades Targets, Buybacks; Brilinta Hopes Rise

29 July 2010, 5:03 am

AstraZeneca gets Brilinta boost, ups guidance

29 July 2010, 3:31 am

AstraZeneca Second-quarter Net Profit Rises 23%

29 July 2010, 2:59 am

Thursday preview: Shell, Astra, BSkyB ...

28 July 2010, 1:16 pm

Teva 2Q profit climbs 53 percent

27 July 2010, 7:36 am

Press Release

27 July 2010, 4:48 am

Courtesy of Yahoo News

Glossary

Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Delist Req.	Patent Expiration
Astrazeneca	PULMICORT RESPULES	budesonide	020929	Aug 8, 2000	RX	No	6,598,603*PED	Y	Jun 23, 2019
Astrazeneca	PULMICORT RESPULES	budesonide	020929	Aug 8, 2000	RX	No	6,899,099*PED	Y	Jun 23, 2019
Astrazeneca	PULMICORT RESPULES	budesonide	020929	Aug 8, 2000	RX	No	7,524,834*PED	Y	May 11, 2019

Export available with Ultimate Plan subscription:

This preview shows a limited data set. Complete access is available with a Subscription

Paragraph IV activity for: PULMICORT RESPULES

Drugname	Dosage	Strength	RLD	Submissiondate
budesonide	Inhalation Suspension	0.25 mg/2 mL and 0.5 mg/2 mL	Pulmicort Respules	9/15/2005

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:
2000 2001 2002 2003 2004
2005 2006 2007 2008 2009

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Follow DrugPatentWatch on Twitter

Bookmark or Share This Page ...